在抗结核药物发现中的目标识别
Rita Capela1, Rita Félix1, Marta Clariano1
1Instituto de Investigação do Medicamento (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal.
International journal of molecular sciences
|July 14, 2023
概括
由于耐药性和对疾病的理解有限,发现结核病 (TB) 的新药很困难. 化学探针有助于识别新的Mycobacterium结核病点,以获得更好的结核病治疗和诊断.
科学领域:
- 微生物学 微生物学
- 药物发现 药物发现 药物发现
- 生物化学 生物化学
背景情况:
- 由Mycobacterium tuberculosis (Mtb) 引起的结核病 (TB) 是一个全球流行病,尽管它是可以预防和治愈的.
- 结核病药物发现的挑战包括Mtb的耐药性,潜伏形式,细胞壁透性和排泄.
- 目前的结核病疗法针对细菌蛋白质的一小部分,突出显示了需要新的治疗策略.
研究的目的:
- 审查结核病药物发现当前的挑战.
- 为了突出MTb中新兴的可药性蛋白质.
- 解释化学探针在识别结核病新目标和生物标志物的作用.
主要方法:
- 审查有关结核病药物发现挑战和Mtb蛋白点的现有文献.
- 讨论化学探针在山脉中进行蛋白质分析的应用.
- 分析如何确定目标和生物标志物的分析可以导致新的治疗和诊断方法.
主要成果:
- 对Mtb病理生理学的有限知识和不充分的体外/体内模型阻碍了药物发现.
- 新兴的可药性Mtb蛋白为治疗干预提供了新的途径.
- 化学探针有助于识别新的Mtb目标和生物标志物.
结论:
- 克服结核病药物发现方面的挑战,需要确定新的点,并开发更好的模型.
- 化学探针是发现新型药用蛋白质和生物标志物的宝贵工具 Mtb.
- 目标识别方面的进步可能会导致结核病的破坏性治疗方案和诊断工具.
更多相关视频
10:29A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
Published on: March 24, 2017
7.9K
09:57Visualization of the Charcoal Agar Resazurin Assay for Semi-quantitative, Medium-throughput Enumeration of Mycobacteria
Published on: December 14, 2016
10.5K
相关概念视频
Pulmonary Tuberculosis V
204
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
204
Pulmonary Tuberculosis IV
165
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
165
Drug Discovery: Overview
8.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.1K
Pulmonary Tuberculosis III
367
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
367
